Prevention of HIV-1 Infection with Early Antiretroviral Therapy

Abstract

The early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy. (Funded by the National Institute of Allergy and Infectious Diseases and others; HPTN 052 ClinicalTrials.gov number, NCT00074581.).

Keywords

MeSH Terms

Affiliated Institutions

• Family Health International 360 US
• Harvard University US
• University of California, Los Angeles US
• Johns Hopkins Medicine US
• University of Zimbabwe ZW
• Kenya Medical Research Institute KE
• Botswana Harvard AIDS Institute Partnership BW
• Hospital Geral de Fortaleza BR
• Johns Hopkins University Center for AIDS Research
• University of North Carolina at Chapel Hill US
• Chiang Mai University TH
• Cancer Research Center US
• University of Nebraska Medical Center US
• National Institutes of Health US
• YR Gaitonde Centre for AIDS Research and Education IN
• Fenway Health US
• National Institute of Allergy and Infectious Diseases US
• National AIDS Research Institute IN
• Instituto Evandro Chagas BR
• Fred Hutch Cancer Center US
• Perinatal HIV Research Unit ZA
• Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa ZA
• Hospital Nossa Senhora da Conceição BR
• Johns Hopkins University US
• University of Washington US
• University of California, San Francisco US

Related Publications